Growth in major Asian economies drives demand for petrochemical products
The COVID-19 epidemic has severely affected the global economy in 2020. GlobalData said that the growth of major Asian economies is expected to rebound in 2021, because containment measures and stimulus programs may increase economic activity in the region and boost demand for petrochemical products.
GlobalData Oil and Gas Analyst John Paul Somavarapu said: “The increase in production capacity in the region is mainly concentrated in China, and the goal is to achieve self-sufficiency to meet the country’s existing and growing demand for petrochemical products. Next are India and Indonesia, which also Taking advantage of their growing demand. The outbreak and falling crude oil prices have prompted petrochemical giants in the two regions to announce project delays. Projects in the early stages of development may be delayed because companies want to reassess their investment strategies."
Because governments of various countries have adopted blockade measures to control the pandemic, the demand for polymers in Asia has been affected. However, the recent increase in industrial/commercial activities and the gradual reopening of the economy will definitely increase the demand for polymers. Due to weak demand and reduced growth in the manufacturing supply chain, demand in key end-use sectors such as construction and automobiles has been affected. However, demand from the packaging and healthcare sectors will sustain the growth of the industry.
Somavalup concluded: “The COVID-19 pandemic is unprecedented. Companies have developed strategies and implemented strict measures to deal with this economic uncertainty and weak growth. Companies use capital investment to maintain existing Asset base, and strategically assess the current situation, and arrange development projects accordingly."
Looking for chemical products? Let suppliers reach out to you!
2026-05-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
-
Roche's Q1 Performance Increases by 10%, And Total Revenue for the Year May Slow Down Due to COVID-19, Biosimilar Competition
Recommend Reading
-
Review of the 93rd API China: In Chongqing, Witnessing the Global Pulse of the Pharmaceutical Industry
-
On the Second Day of the 93rd API China: ECHEMI Advances Global Dialogue in the Pharmaceutical Industry Through Innovative Practices
-
From API China to the Global Pharmaceutical Chain: ECHEMI Is Reshaping the "New Speed" of Pharmaceutical Trade
-
When Global Buyers Sit at the Same Table, Chinese Suppliers Respond: A Real 1-on-1 Online Business Matching Event
-
When Global Buyers No Longer Visit Trade Shows but “Select Suppliers with a Click”
-
Supply Chain Resilience Reshapes Chemical Competition: What Lies Behind BASF’s Stable Outlook
-
German Continental Group’s Strategic Move for the €110B Automotive Semiconductor Market
-
Dow to Shut Down 3 European Facilities Impacting 800 Jobs
-
SK Chemicals Partners with China’s Kelinle to Build Its Own Waste-Plastic Supply Network
-
Breakthrough in Materials Technology 200μm Thick Films Achieve Unprecedented Precision